Obmolova; Galina
Patent Applications and Registrations
Patent applications and USPTO patent grants for Obmolova; Galina.The latest application filed is for "anti-cd154 antibodies and methods of using them".
- Obmolova; Galina - Spring House PA
- Obmolova; Galina - Phoenixville PA
- Obmolova; Galina - Radnor PA
| Patent | Date |
|---|---|
| Nucleic acids encoding anti-CD154 antibodies Grant 11,421,037 - Fransson , et al. August 23, 2 | 2022-08-23 |
| Anti-cd154 Antibodies And Methods Of Using Them App 20200317794 - Fransson; Johan ; et al. | 2020-10-08 |
| Human Anti-CD27 Antibodies App 20200277393 - Chen; John ; et al. | 2020-09-03 |
| Interferon alpha and omega antibody antagonists Grant 10,759,854 - Chi , et al. Sep | 2020-09-01 |
| Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies Grant 10,689,453 - Chen , et al. | 2020-06-23 |
| Anti-CD154 antibodies and methods of using them Grant 10,669,343 - Fransson , et al. | 2020-06-02 |
| Interferon Alpha and Omega Antibody Antagonists App 20190359705 - Chi; Ellen ; et al. | 2019-11-28 |
| Methods of Inhibiting Activity Using Anti-CD27 Antibodies App 20190248910 - Chen; John ; et al. | 2019-08-15 |
| Interferon alpha and omega antibody antagonists Grant 10,358,491 - Chi , et al. | 2019-07-23 |
| Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies Grant 10,301,392 - Chen , et al. | 2019-05-28 |
| Interferon Alpha and Omega Antibody Antagonists App 20190135912 - Chi; Ellen ; et al. | 2019-05-09 |
| Interferon Alpha and Omega Antibody Antagonists App 20190106489 - Chi; Ellen ; et al. | 2019-04-11 |
| Interferon .alpha. and .omega. antibody antagonists Grant 10,208,113 - Chi , et al. Feb | 2019-02-19 |
| Interferon alpha and omega antibody antagonists Grant 10,155,809 - Chi , et al. Dec | 2018-12-18 |
| Antibodies Specifically Binding HLA-DR and Their Uses App 20180355043 - Martinez; Christian ; et al. | 2018-12-13 |
| Interferon alpha and omega antibody antagonists Grant 9,902,770 - Chi , et al. February 27, 2 | 2018-02-27 |
| Interferon Alpha and Omega Antibody Antagonists App 20180002418 - Chi; Ellen ; et al. | 2018-01-04 |
| Methods of Inhibiting Activity Using Anti-CD27 Antibodies App 20170320957 - Chen; John ; et al. | 2017-11-09 |
| Nucleic acid molecules encoding anti-CD27 antibodies Grant 9,683,046 - Chen , et al. June 20, 2 | 2017-06-20 |
| Anti-CD154 antibodies and methods of using them App 20170037136 - Fransson; Johan ; et al. | 2017-02-09 |
| Interferon Alpha and Omega Antibody Antagonists App 20150368338 - Chi; Ellen ; et al. | 2015-12-24 |
| Human Anti-CD27 Antibodies, Methods and Uses App 20150299330 - Chen; John ; et al. | 2015-10-22 |
| Human anti-CD27 antibodies, methods and uses Grant 9,102,737 - Chen , et al. August 11, 2 | 2015-08-11 |
| Interferon Alpha and Omega Antibody Antagonists App 20140271648 - Chi; Ellen ; et al. | 2014-09-18 |
| Human Anti-cd27 Antibodies, Methods And Uses App 20130243795 - Chen; John ; et al. | 2013-09-19 |
| IL-17A antibodies Grant 8,519,107 - Almagro , et al. August 27, 2 | 2013-08-27 |
| IL-17A Antagonists App 20110236390 - Almagro; Juan Carlos ; et al. | 2011-09-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 